康美药业
(600518)
| 流通市值：223.92亿 | | | 总市值：224.03亿 |
| 流通股本：138.22亿 | | | 总股本：138.29亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,228,787,192.41 | 1,240,084,497.95 | 1,180,626,875.64 | 902,625,974.08 |
| 交易性金融资产 | 83,435.68 | 87,646.51 | 91,402.64 | 80,045.27 |
| 应收票据及应收账款 | 2,430,082,161.63 | 2,361,199,506.75 | 2,519,001,801.67 | 2,600,056,254.48 |
| 其中：应收票据 | 62,399,561.63 | 61,969,126.13 | 45,396,096.1 | 43,155,310.98 |
| 应收账款 | 2,367,682,600 | 2,299,230,380.62 | 2,473,605,705.57 | 2,556,900,943.5 |
| 应收款项融资 | 35,144,488.1 | 63,223,246.45 | 55,238,978.27 | 32,220,986.97 |
| 预付款项 | 128,077,382.86 | 142,596,682.09 | 87,677,133.58 | 96,544,656.32 |
| 其他应收款合计 | 455,268,356.1 | 451,265,880.87 | 574,344,551.93 | 658,401,207.51 |
| 存货 | 2,378,798,285.97 | 2,236,515,651.5 | 2,452,703,655.87 | 2,440,432,694.78 |
| 其他流动资产 | 147,226,434.87 | 156,455,168.86 | 159,616,923.15 | 170,601,733.93 |
| 流动资产合计 | 6,803,467,737.62 | 6,651,428,280.98 | 7,029,301,322.75 | 6,900,963,553.34 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 1,045,458.57 | 1,044,664.83 | 1,045,560.24 | 1,081,681.93 |
| 投资性房地产 | 2,510,830,621.93 | 2,534,223,667.59 | 2,682,870,160.98 | 2,687,036,631.5 |
| 固定资产 | 3,164,510,086.6 | 3,204,070,255.17 | 3,068,634,809.9 | 3,136,522,116.31 |
| 在建工程 | 175,686,182.84 | 164,800,076.86 | 170,681,750.53 | 171,865,956.83 |
| 生产性生物资产 | 354,523.12 | 358,702.39 | 366,842.66 | 371,030.42 |
| 使用权资产 | 86,534,234.74 | 82,051,926.7 | 93,032,657.78 | 102,120,219.34 |
| 无形资产 | 409,019,671.4 | 413,934,506.89 | 391,476,344.91 | 400,994,331.39 |
| 商誉 | 36,909,405.61 | 36,909,405.61 | 106,350,551.22 | 106,350,551.22 |
| 长期待摊费用 | 47,409,470.99 | 49,987,043.36 | 49,436,826.61 | 50,264,664.08 |
| 递延所得税资产 | 64,065,485.53 | 64,172,303.24 | 67,526,844.48 | 70,234,521.97 |
| 其他非流动资产 | 7,453,338.15 | 16,765,153.88 | 22,210,835.91 | 16,933,612.28 |
| 非流动资产合计 | 6,503,818,479.48 | 6,568,317,706.52 | 6,653,633,185.22 | 6,743,775,317.27 |
| 资产总计 | 13,307,286,217.1 | 13,219,745,987.5 | 13,682,934,507.97 | 13,644,738,870.61 |
| 流动负债: | | | | |
| 短期借款 | 81,592,942.46 | 90,931,770.52 | 14,839,858.44 | 20,095,785.03 |
| 应付票据及应付账款 | 2,455,043,400.62 | 2,354,806,456.3 | 2,608,535,602.99 | 2,485,301,423.79 |
| 其中：应付票据 | 167,518,054.17 | 124,333,748.26 | 74,694,835.99 | 53,176,542.69 |
| 应付账款 | 2,287,525,346.45 | 2,230,472,708.04 | 2,533,840,767 | 2,432,124,881.1 |
| 预收款项 | 49,226,337.48 | 48,908,196.9 | 60,217,549.57 | 53,023,462.64 |
| 合同负债 | 112,071,696.06 | 91,696,441.12 | 146,866,646.77 | 136,114,204.06 |
| 应付职工薪酬 | 66,492,613.95 | 70,848,303.62 | 58,809,559.17 | 56,961,942.31 |
| 应交税费 | 424,921,788.2 | 425,574,193.96 | 418,707,947.52 | 411,689,366.12 |
| 其他应付款合计 | 1,190,382,733.94 | 1,184,641,797.75 | 1,252,239,614.92 | 1,289,909,664.19 |
| 应付股利 | 4,750,000 | 5,000,000 | 2,250,000 | 2,250,000 |
| 一年内到期的非流动负债 | 23,547,256.43 | 23,544,474.33 | 25,302,411.46 | 27,297,236.08 |
| 其他流动负债 | 974,339,884 | 974,939,354.28 | 1,225,891,717.94 | 1,273,082,383.61 |
| 流动负债合计 | 5,377,618,653.14 | 5,265,890,988.78 | 5,811,410,908.78 | 5,753,475,467.83 |
| 非流动负债: | | | | |
| 租赁负债 | 68,571,833.75 | 69,888,199.67 | 78,445,921.89 | 84,243,095.09 |
| 预计负债 | 16,205,452.06 | 16,248,337.06 | 17,092,873.6 | 17,653,514.34 |
| 递延收益 | 516,200,756.88 | 523,013,728.48 | 530,151,217.7 | 538,414,607.03 |
| 递延所得税负债 | 19,185,619.26 | 19,297,198.53 | 21,150,419.62 | 23,972,549.88 |
| 非流动负债合计 | 620,163,661.95 | 628,447,463.74 | 646,840,432.81 | 664,283,766.34 |
| 负债合计 | 5,997,782,315.09 | 5,894,338,452.52 | 6,458,251,341.59 | 6,417,759,234.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 13,828,896,690 | 13,828,896,690 | 13,828,896,690 | 13,863,866,690 |
| 资本公积 | 18,474,263,009.57 | 18,474,263,009.57 | 18,474,263,009.57 | 18,782,890,509.57 |
| 减:库存股 | 659,922,053.5 | 659,922,053.5 | 763,916,500 | 1,107,514,000 |
| 其他综合收益 | -361,053.62 | -345,247.63 | -333,915.4 | -294,658.08 |
| 专项储备 | 3,663,932.71 | 3,571,061.85 | 1,567,853.73 | 1,500,536.35 |
| 盈余公积 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 |
| 未分配利润 | -25,898,596,860.1 | -25,882,032,977.71 | -25,879,278,666.17 | -25,875,459,585.62 |
| 归属于母公司股东权益合计 | 7,273,519,463.33 | 7,290,006,280.85 | 7,186,774,270 | 7,190,565,290.49 |
| 少数股东权益 | 35,984,438.68 | 35,401,254.13 | 37,908,896.38 | 36,414,345.95 |
| 股东权益合计 | 7,309,503,902.01 | 7,325,407,534.98 | 7,224,683,166.38 | 7,226,979,636.44 |
| 负债和股东权益合计 | 13,307,286,217.1 | 13,219,745,987.5 | 13,682,934,507.97 | 13,644,738,870.61 |
| 公告日期 | 2026-04-30 | 2026-04-18 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |